Abbott Diagnostics Division has found that the oxymorphone cross-reactivity information in the 'Specific Performance Characteristics' section of the TDx/TDxFLx Opiates Reagent package insert (commodity number 32-2087/R5) does not match the current product performance.
Source facts
Action
A Device Correction Letter dated 5/28/04 was mailed to all customers. The letter explained the reason for the recall and provided specific instructions.
Initiated
2004-05-28
Root cause
Other
Terminated
2004-09-10
Distribution
Distribution was to hospitals/laboratories
Recall number
Z-1229-04
Recall status
Terminated
CDRH record ID
33478
FDA classified
2004-07-28
Recall event number
29289
Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.
Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.